Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Genoptix, Inc.
Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
March 1st, 2008
Genoptix, Inc. (NASDAQ:GXDX), announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed secondary public offering of 4,200,000 shares of common stock. The shares of common stock to be registered are currently owned and will be offered and sold by certain existing stockholders, who will receive all of the net proceeds from this offering. Genoptix, Inc. will not be selling any shares of its common stock and will not receive any proceeds from the sale of the shares of common stock being registered. There can be no assurance as to whether or when any such offering would commence or be completed, or as to the actual size or terms of any such...
Source: Law & Health Weekly (2008-03-01)
|
